Non-apoptotic cell death in malignant tumor cells and natural compounds
Traditional cancer therapy is mainly targeting on enhancing cell apoptosis, however, it is well established that many cancer cells are chemo-resistant and defective in apoptosis induction. Therefore, it may have important therapeutic implications to exploit some novel natural compounds based on non-...
Gespeichert in:
Veröffentlicht in: | Cancer letters 2018-04, Vol.420, p.210-227 |
---|---|
Hauptverfasser: | , , , , , , , |
Format: | Artikel |
Sprache: | eng |
Schlagworte: | |
Online-Zugang: | Volltext |
Tags: |
Tag hinzufügen
Keine Tags, Fügen Sie den ersten Tag hinzu!
|
container_end_page | 227 |
---|---|
container_issue | |
container_start_page | 210 |
container_title | Cancer letters |
container_volume | 420 |
creator | Ye, Jing Zhang, Ruonan Wu, Fan Zhai, Lijuan Wang, Kaifeng Xiao, Mang Xie, Tian Sui, Xinbing |
description | Traditional cancer therapy is mainly targeting on enhancing cell apoptosis, however, it is well established that many cancer cells are chemo-resistant and defective in apoptosis induction. Therefore, it may have important therapeutic implications to exploit some novel natural compounds based on non-apoptotic programmed cell death. Currently, accumulating evidence shows that the compounds from nature source can induce non-apoptotic programmed cell death in cancer cells, and therefore these natural compounds have gained a great promise for the future anticancer therapeutics. In this review, we will concentrate our efforts on the latest developments regarding major forms of non-apoptotic programmed cell death--autophagic cell death, necroptosis, ferroptosis, pyroptosis, glutamoptosis and exosome-associated cell death. Our increased understanding of the role of natural compounds in regulating non-apoptotic programmed cell death will hopefully provide prospective strategies for cancer therapy.
•It is well established that many cancer cells are chemo-resistant and defective in apoptosis induction.•It may have important therapeutic implications to exploit some novel natural compounds based on non-apoptotic programmed cell death.•The compounds from nature source can induce non-apoptotic programmed cell death in cancer cells.•Our increased understanding of the role of natural compounds in regulating non-apoptotic programmed cell death will hopefully provide prospective strategies for cancer therapy. |
doi_str_mv | 10.1016/j.canlet.2018.01.061 |
format | Article |
fullrecord | <record><control><sourceid>proquest_cross</sourceid><recordid>TN_cdi_proquest_miscellaneous_1999192431</recordid><sourceformat>XML</sourceformat><sourcesystem>PC</sourcesystem><els_id>S0304383518300946</els_id><sourcerecordid>2012201285</sourcerecordid><originalsourceid>FETCH-LOGICAL-c456t-e5c4e8600b8222ea3aa8a748eb12279f2df2fb115a089e7317ac717aa0b9de953</originalsourceid><addsrcrecordid>eNp9kE1rFTEUhoMo9rb6D0QG3HQz40nmK9kIUmorlLrRdTiTOaO5zCRjkin035vxVhcuXCQh5HnfHB7G3nCoOPDu_bEy6GZKlQAuK-AVdPwZO3DZi7JXEp6zA9TQlLWs2zN2HuMRANqmb1-yM6Eanm_dgd3ce1fi6tfkkzWFoXkuRsL0o7CuWHC23x26VKRt8eH3ayzQjYXDtAWcC-OX1W9ujK_YiwnnSK-fzgv27dP116vb8u7Lzeerj3eladouldSahmQHMEghBGGNKLFvJA1ciF5NYpzENHDeIkhFfc17NH3eEAY1kmrrC3Z56l2D_7lRTHqxcZ8LHfktaq6U4ko0Nc_ou3_Qo9-Cy9PprEzsS-6FzYkywccYaNJrsAuGR81B76L1UZ9E7ympgessOsfePpVvw0Lj39Afsxn4cAIo23iwFHQ0lpyh0QYySY_e_v-HXzqoj6A</addsrcrecordid><sourcetype>Aggregation Database</sourcetype><iscdi>true</iscdi><recordtype>article</recordtype><pqid>2012201285</pqid></control><display><type>article</type><title>Non-apoptotic cell death in malignant tumor cells and natural compounds</title><source>MEDLINE</source><source>Elsevier ScienceDirect Journals Complete</source><creator>Ye, Jing ; Zhang, Ruonan ; Wu, Fan ; Zhai, Lijuan ; Wang, Kaifeng ; Xiao, Mang ; Xie, Tian ; Sui, Xinbing</creator><creatorcontrib>Ye, Jing ; Zhang, Ruonan ; Wu, Fan ; Zhai, Lijuan ; Wang, Kaifeng ; Xiao, Mang ; Xie, Tian ; Sui, Xinbing</creatorcontrib><description>Traditional cancer therapy is mainly targeting on enhancing cell apoptosis, however, it is well established that many cancer cells are chemo-resistant and defective in apoptosis induction. Therefore, it may have important therapeutic implications to exploit some novel natural compounds based on non-apoptotic programmed cell death. Currently, accumulating evidence shows that the compounds from nature source can induce non-apoptotic programmed cell death in cancer cells, and therefore these natural compounds have gained a great promise for the future anticancer therapeutics. In this review, we will concentrate our efforts on the latest developments regarding major forms of non-apoptotic programmed cell death--autophagic cell death, necroptosis, ferroptosis, pyroptosis, glutamoptosis and exosome-associated cell death. Our increased understanding of the role of natural compounds in regulating non-apoptotic programmed cell death will hopefully provide prospective strategies for cancer therapy.
•It is well established that many cancer cells are chemo-resistant and defective in apoptosis induction.•It may have important therapeutic implications to exploit some novel natural compounds based on non-apoptotic programmed cell death.•The compounds from nature source can induce non-apoptotic programmed cell death in cancer cells.•Our increased understanding of the role of natural compounds in regulating non-apoptotic programmed cell death will hopefully provide prospective strategies for cancer therapy.</description><identifier>ISSN: 0304-3835</identifier><identifier>EISSN: 1872-7980</identifier><identifier>DOI: 10.1016/j.canlet.2018.01.061</identifier><identifier>PMID: 29410006</identifier><language>eng</language><publisher>Ireland: Elsevier B.V</publisher><subject>Angiogenesis ; Apoptosis ; Autophagy ; Biological Products - chemistry ; Biological Products - pharmacology ; Biological Products - therapeutic use ; Breast cancer ; Cancer ; Cancer therapies ; Cell Death ; Cell Line, Tumor ; Exosomes - drug effects ; Exosomes - metabolism ; Ferroptosis ; Humans ; Kinases ; Lymphoma ; Mammals ; Natural compounds ; Necroptosis ; Neoplasms - drug therapy ; Neoplasms - metabolism ; Non-apoptotic cell death ; Proteins ; Pyroptosis ; Signal transduction ; Stem cells ; Tumor cells ; Tumors</subject><ispartof>Cancer letters, 2018-04, Vol.420, p.210-227</ispartof><rights>2018 Elsevier B.V.</rights><rights>Copyright © 2018 Elsevier B.V. All rights reserved.</rights><rights>2018. Elsevier B.V.</rights><lds50>peer_reviewed</lds50><woscitedreferencessubscribed>false</woscitedreferencessubscribed><citedby>FETCH-LOGICAL-c456t-e5c4e8600b8222ea3aa8a748eb12279f2df2fb115a089e7317ac717aa0b9de953</citedby><cites>FETCH-LOGICAL-c456t-e5c4e8600b8222ea3aa8a748eb12279f2df2fb115a089e7317ac717aa0b9de953</cites></display><links><openurl>$$Topenurl_article</openurl><openurlfulltext>$$Topenurlfull_article</openurlfulltext><thumbnail>$$Tsyndetics_thumb_exl</thumbnail><linktohtml>$$Uhttps://www.sciencedirect.com/science/article/pii/S0304383518300946$$EHTML$$P50$$Gelsevier$$H</linktohtml><link.rule.ids>314,776,780,3537,27901,27902,65534</link.rule.ids><backlink>$$Uhttps://www.ncbi.nlm.nih.gov/pubmed/29410006$$D View this record in MEDLINE/PubMed$$Hfree_for_read</backlink></links><search><creatorcontrib>Ye, Jing</creatorcontrib><creatorcontrib>Zhang, Ruonan</creatorcontrib><creatorcontrib>Wu, Fan</creatorcontrib><creatorcontrib>Zhai, Lijuan</creatorcontrib><creatorcontrib>Wang, Kaifeng</creatorcontrib><creatorcontrib>Xiao, Mang</creatorcontrib><creatorcontrib>Xie, Tian</creatorcontrib><creatorcontrib>Sui, Xinbing</creatorcontrib><title>Non-apoptotic cell death in malignant tumor cells and natural compounds</title><title>Cancer letters</title><addtitle>Cancer Lett</addtitle><description>Traditional cancer therapy is mainly targeting on enhancing cell apoptosis, however, it is well established that many cancer cells are chemo-resistant and defective in apoptosis induction. Therefore, it may have important therapeutic implications to exploit some novel natural compounds based on non-apoptotic programmed cell death. Currently, accumulating evidence shows that the compounds from nature source can induce non-apoptotic programmed cell death in cancer cells, and therefore these natural compounds have gained a great promise for the future anticancer therapeutics. In this review, we will concentrate our efforts on the latest developments regarding major forms of non-apoptotic programmed cell death--autophagic cell death, necroptosis, ferroptosis, pyroptosis, glutamoptosis and exosome-associated cell death. Our increased understanding of the role of natural compounds in regulating non-apoptotic programmed cell death will hopefully provide prospective strategies for cancer therapy.
•It is well established that many cancer cells are chemo-resistant and defective in apoptosis induction.•It may have important therapeutic implications to exploit some novel natural compounds based on non-apoptotic programmed cell death.•The compounds from nature source can induce non-apoptotic programmed cell death in cancer cells.•Our increased understanding of the role of natural compounds in regulating non-apoptotic programmed cell death will hopefully provide prospective strategies for cancer therapy.</description><subject>Angiogenesis</subject><subject>Apoptosis</subject><subject>Autophagy</subject><subject>Biological Products - chemistry</subject><subject>Biological Products - pharmacology</subject><subject>Biological Products - therapeutic use</subject><subject>Breast cancer</subject><subject>Cancer</subject><subject>Cancer therapies</subject><subject>Cell Death</subject><subject>Cell Line, Tumor</subject><subject>Exosomes - drug effects</subject><subject>Exosomes - metabolism</subject><subject>Ferroptosis</subject><subject>Humans</subject><subject>Kinases</subject><subject>Lymphoma</subject><subject>Mammals</subject><subject>Natural compounds</subject><subject>Necroptosis</subject><subject>Neoplasms - drug therapy</subject><subject>Neoplasms - metabolism</subject><subject>Non-apoptotic cell death</subject><subject>Proteins</subject><subject>Pyroptosis</subject><subject>Signal transduction</subject><subject>Stem cells</subject><subject>Tumor cells</subject><subject>Tumors</subject><issn>0304-3835</issn><issn>1872-7980</issn><fulltext>true</fulltext><rsrctype>article</rsrctype><creationdate>2018</creationdate><recordtype>article</recordtype><sourceid>EIF</sourceid><recordid>eNp9kE1rFTEUhoMo9rb6D0QG3HQz40nmK9kIUmorlLrRdTiTOaO5zCRjkin035vxVhcuXCQh5HnfHB7G3nCoOPDu_bEy6GZKlQAuK-AVdPwZO3DZi7JXEp6zA9TQlLWs2zN2HuMRANqmb1-yM6Eanm_dgd3ce1fi6tfkkzWFoXkuRsL0o7CuWHC23x26VKRt8eH3ayzQjYXDtAWcC-OX1W9ujK_YiwnnSK-fzgv27dP116vb8u7Lzeerj3eladouldSahmQHMEghBGGNKLFvJA1ciF5NYpzENHDeIkhFfc17NH3eEAY1kmrrC3Z56l2D_7lRTHqxcZ8LHfktaq6U4ko0Nc_ou3_Qo9-Cy9PprEzsS-6FzYkywccYaNJrsAuGR81B76L1UZ9E7ympgessOsfePpVvw0Lj39Afsxn4cAIo23iwFHQ0lpyh0QYySY_e_v-HXzqoj6A</recordid><startdate>20180428</startdate><enddate>20180428</enddate><creator>Ye, Jing</creator><creator>Zhang, Ruonan</creator><creator>Wu, Fan</creator><creator>Zhai, Lijuan</creator><creator>Wang, Kaifeng</creator><creator>Xiao, Mang</creator><creator>Xie, Tian</creator><creator>Sui, Xinbing</creator><general>Elsevier B.V</general><general>Elsevier Limited</general><scope>CGR</scope><scope>CUY</scope><scope>CVF</scope><scope>ECM</scope><scope>EIF</scope><scope>NPM</scope><scope>AAYXX</scope><scope>CITATION</scope><scope>7TO</scope><scope>7U9</scope><scope>H94</scope><scope>K9.</scope><scope>NAPCQ</scope><scope>7X8</scope></search><sort><creationdate>20180428</creationdate><title>Non-apoptotic cell death in malignant tumor cells and natural compounds</title><author>Ye, Jing ; Zhang, Ruonan ; Wu, Fan ; Zhai, Lijuan ; Wang, Kaifeng ; Xiao, Mang ; Xie, Tian ; Sui, Xinbing</author></sort><facets><frbrtype>5</frbrtype><frbrgroupid>cdi_FETCH-LOGICAL-c456t-e5c4e8600b8222ea3aa8a748eb12279f2df2fb115a089e7317ac717aa0b9de953</frbrgroupid><rsrctype>articles</rsrctype><prefilter>articles</prefilter><language>eng</language><creationdate>2018</creationdate><topic>Angiogenesis</topic><topic>Apoptosis</topic><topic>Autophagy</topic><topic>Biological Products - chemistry</topic><topic>Biological Products - pharmacology</topic><topic>Biological Products - therapeutic use</topic><topic>Breast cancer</topic><topic>Cancer</topic><topic>Cancer therapies</topic><topic>Cell Death</topic><topic>Cell Line, Tumor</topic><topic>Exosomes - drug effects</topic><topic>Exosomes - metabolism</topic><topic>Ferroptosis</topic><topic>Humans</topic><topic>Kinases</topic><topic>Lymphoma</topic><topic>Mammals</topic><topic>Natural compounds</topic><topic>Necroptosis</topic><topic>Neoplasms - drug therapy</topic><topic>Neoplasms - metabolism</topic><topic>Non-apoptotic cell death</topic><topic>Proteins</topic><topic>Pyroptosis</topic><topic>Signal transduction</topic><topic>Stem cells</topic><topic>Tumor cells</topic><topic>Tumors</topic><toplevel>peer_reviewed</toplevel><toplevel>online_resources</toplevel><creatorcontrib>Ye, Jing</creatorcontrib><creatorcontrib>Zhang, Ruonan</creatorcontrib><creatorcontrib>Wu, Fan</creatorcontrib><creatorcontrib>Zhai, Lijuan</creatorcontrib><creatorcontrib>Wang, Kaifeng</creatorcontrib><creatorcontrib>Xiao, Mang</creatorcontrib><creatorcontrib>Xie, Tian</creatorcontrib><creatorcontrib>Sui, Xinbing</creatorcontrib><collection>Medline</collection><collection>MEDLINE</collection><collection>MEDLINE (Ovid)</collection><collection>MEDLINE</collection><collection>MEDLINE</collection><collection>PubMed</collection><collection>CrossRef</collection><collection>Oncogenes and Growth Factors Abstracts</collection><collection>Virology and AIDS Abstracts</collection><collection>AIDS and Cancer Research Abstracts</collection><collection>ProQuest Health & Medical Complete (Alumni)</collection><collection>Nursing & Allied Health Premium</collection><collection>MEDLINE - Academic</collection><jtitle>Cancer letters</jtitle></facets><delivery><delcategory>Remote Search Resource</delcategory><fulltext>fulltext</fulltext></delivery><addata><au>Ye, Jing</au><au>Zhang, Ruonan</au><au>Wu, Fan</au><au>Zhai, Lijuan</au><au>Wang, Kaifeng</au><au>Xiao, Mang</au><au>Xie, Tian</au><au>Sui, Xinbing</au><format>journal</format><genre>article</genre><ristype>JOUR</ristype><atitle>Non-apoptotic cell death in malignant tumor cells and natural compounds</atitle><jtitle>Cancer letters</jtitle><addtitle>Cancer Lett</addtitle><date>2018-04-28</date><risdate>2018</risdate><volume>420</volume><spage>210</spage><epage>227</epage><pages>210-227</pages><issn>0304-3835</issn><eissn>1872-7980</eissn><abstract>Traditional cancer therapy is mainly targeting on enhancing cell apoptosis, however, it is well established that many cancer cells are chemo-resistant and defective in apoptosis induction. Therefore, it may have important therapeutic implications to exploit some novel natural compounds based on non-apoptotic programmed cell death. Currently, accumulating evidence shows that the compounds from nature source can induce non-apoptotic programmed cell death in cancer cells, and therefore these natural compounds have gained a great promise for the future anticancer therapeutics. In this review, we will concentrate our efforts on the latest developments regarding major forms of non-apoptotic programmed cell death--autophagic cell death, necroptosis, ferroptosis, pyroptosis, glutamoptosis and exosome-associated cell death. Our increased understanding of the role of natural compounds in regulating non-apoptotic programmed cell death will hopefully provide prospective strategies for cancer therapy.
•It is well established that many cancer cells are chemo-resistant and defective in apoptosis induction.•It may have important therapeutic implications to exploit some novel natural compounds based on non-apoptotic programmed cell death.•The compounds from nature source can induce non-apoptotic programmed cell death in cancer cells.•Our increased understanding of the role of natural compounds in regulating non-apoptotic programmed cell death will hopefully provide prospective strategies for cancer therapy.</abstract><cop>Ireland</cop><pub>Elsevier B.V</pub><pmid>29410006</pmid><doi>10.1016/j.canlet.2018.01.061</doi><tpages>18</tpages></addata></record> |
fulltext | fulltext |
identifier | ISSN: 0304-3835 |
ispartof | Cancer letters, 2018-04, Vol.420, p.210-227 |
issn | 0304-3835 1872-7980 |
language | eng |
recordid | cdi_proquest_miscellaneous_1999192431 |
source | MEDLINE; Elsevier ScienceDirect Journals Complete |
subjects | Angiogenesis Apoptosis Autophagy Biological Products - chemistry Biological Products - pharmacology Biological Products - therapeutic use Breast cancer Cancer Cancer therapies Cell Death Cell Line, Tumor Exosomes - drug effects Exosomes - metabolism Ferroptosis Humans Kinases Lymphoma Mammals Natural compounds Necroptosis Neoplasms - drug therapy Neoplasms - metabolism Non-apoptotic cell death Proteins Pyroptosis Signal transduction Stem cells Tumor cells Tumors |
title | Non-apoptotic cell death in malignant tumor cells and natural compounds |
url | https://sfx.bib-bvb.de/sfx_tum?ctx_ver=Z39.88-2004&ctx_enc=info:ofi/enc:UTF-8&ctx_tim=2025-02-19T06%3A48%3A51IST&url_ver=Z39.88-2004&url_ctx_fmt=infofi/fmt:kev:mtx:ctx&rfr_id=info:sid/primo.exlibrisgroup.com:primo3-Article-proquest_cross&rft_val_fmt=info:ofi/fmt:kev:mtx:journal&rft.genre=article&rft.atitle=Non-apoptotic%20cell%20death%20in%20malignant%20tumor%20cells%20and%20natural%20compounds&rft.jtitle=Cancer%20letters&rft.au=Ye,%20Jing&rft.date=2018-04-28&rft.volume=420&rft.spage=210&rft.epage=227&rft.pages=210-227&rft.issn=0304-3835&rft.eissn=1872-7980&rft_id=info:doi/10.1016/j.canlet.2018.01.061&rft_dat=%3Cproquest_cross%3E2012201285%3C/proquest_cross%3E%3Curl%3E%3C/url%3E&disable_directlink=true&sfx.directlink=off&sfx.report_link=0&rft_id=info:oai/&rft_pqid=2012201285&rft_id=info:pmid/29410006&rft_els_id=S0304383518300946&rfr_iscdi=true |